Zantac (ranitidine)
Zantac was pulled from the U.S. market in 2020 over a contaminant concern. Most related lawsuits have been dismissed or settled, so this page is informational.
- Case group
- MDL 2924
- Court
- S.D. Florida
- Centralized
- Feb 6, 2020
- Pending cases
- 847Sep 1, 2026
We're not accepting review requests here
Federal MDL claims were dismissed after 2022 Daubert ruling (appeal pending); GSK settled most state cases; Delaware court granted summary judgment in April 2026.
See campaigns accepting reviewsWhere things stand
- Apr 1, 2020FDA requested withdrawal of all ranitidine products due to NDMA impurity.
- Dec 2022News outlets reported a development we are still confirming against the court record.Being verified
- Apr 13, 2026News outlets reported a development we are still confirming against the court record.Being verified
Records that usually help
You don't need these to start. Don't upload them here — a firm will ask if it needs them.
- Pharmacy records or OTC purchase evidence
- Cancer diagnosis and pathology report
- Treatment records
About filing deadlines
Deadlines to file a claim vary by state and situation, and some may already have passed. Only a licensed attorney can tell you whether a deadline applies to you. Submitting here does not stop any deadline.
Attorney advertising. TortMatics (FusionByte Media LLC) is not a law firm. Information on this page is general and is not medical or legal advice. Talk to a doctor before changing any medication.